<code id='7BB6161168'></code><style id='7BB6161168'></style>

<acronym id='7BB6161168'></acronym>

<center id='7BB6161168'><center id='7BB6161168'><tfoot id='7BB6161168'></tfoot></center><abbr id='7BB6161168'><dir id='7BB6161168'><tfoot id='7BB6161168'></tfoot><noframes id='7BB6161168'>

<optgroup id='7BB6161168'><strike id='7BB6161168'><sup id='7BB6161168'></sup></strike><code id='7BB6161168'></code></optgroup>

<b id='7BB6161168'><label id='7BB6161168'><select id='7BB6161168'><dt id='7BB6161168'><span id='7BB6161168'></span></dt></select></label></b><u id='7BB6161168'></u>

~~<i id='7BB6161168'><strike id='7BB6161168'><tt id='7BB6161168'><pre id='7BB6161168'></pre></tt></strike></i>~~

Home» leisure time» hotspot

hotspot

hotspot

author：explore 2025-09-27 10:32:43 Page View：2

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

advertisement

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hilary may become 1st tropical storm to make landfall in California in 84 years
Next article： Medical leaders decry Supreme Court decision on affirmative action

explore

Cancer drug shortages should be causing more outrage

Cancer drug shortages should be causing more outrage

DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

ProMED sees offers of support, but its future remains unclear

ProMED sees offers of support, but its future remains unclear

ProMEDmapScreengrabviaProMEDWithitsfutureindoubt,ProMED,thefinanciallystrappedinfectiousdiseasessurv

Walensky prepares to leave CDC — and Congress — behind

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

1:03JackSmith,thentheDepartmentofJustice'schiefofthePublicIntegritySection,posesforphotoattheDepartm

read more